Receptor interacting serine/threonine kinase 2 promotes rheumatoid arthritis progression and partially regulates

Yanzheng Wang1, Meiyu Xu2, Xinxin Liu3

  • 1Department of Medical Laboratory, Yantaishan Hospital, Yantai, China.

Cytojournal
|December 31, 2024
PubMed
Abstract

Insights

Receptor-interacting serine/threonine kinase 2 (RIPK2) is highly expressed in rheumatoid arthritis (RA). Silencing RIPK2 reduces RA fibroblast-like synoviocyte proliferation and inflammation, suggesting RIPK2 as a therapeutic target.

Area of Science:

  • Immunology
  • Molecular Biology
  • Rheumatology

Background:

  • Rheumatoid arthritis (RA) is a debilitating systemic autoimmune disease with largely unknown molecular pathways.
  • Receptor-interacting serine/threonine kinase 2 (RIPK2) is implicated in inflammatory processes.

Purpose of the Study:

  • To investigate the role of RIPK2 in rheumatoid arthritis (RA) progression.
  • To elucidate the underlying molecular mechanisms of RIPK2 in RA pathogenesis.

Main Methods:

  • Quantitative PCR, immunohistochemistry, and Western blot were used to analyze RIPK2 expression in RA tissues and cells.
  • Cell counting kit-8, 5-ethynyl-2'-deoxyuridine, transwell, and wound healing assays assessed cell proliferation, invasion, and migration.
  • Flow cytometry and ELISA measured apoptosis and inflammatory factors, respectively.
  • Western blot analyzed the nuclear factor kappa B (NF-κB) pathway.

Main Results:

  • RIPK2 was significantly upregulated in RA synovial tissues and fibroblast-like synoviocytes (FLS).
  • RIPK2 silencing in RA-FLS cells inhibited proliferation, invasion, and migration, while promoting apoptosis.
  • Silencing RIPK2 suppressed inflammatory responses and partially modulated the NF-κB pathway in RA-FLS cells.

Conclusions:

  • RIPK2 plays a crucial role in the malignant behavior and inflammatory response of RA-FLS.
  • Targeting RIPK2 may offer a potential therapeutic strategy for rheumatoid arthritis by modulating the NF-κB pathway.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
8.3K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.2K
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
613
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.2K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
4.9K
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.3K